Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine
Nuclidium images first patient in phase II trial of Cu-61 PSMA tracer
By
AuntMinnieEurope.com staff writers
The trial will enroll nearly three dozen patients with biopsy-confirmed metastatic prostate cancer at U.S. sites.
October 6, 2026
GE HealthCare to acquire Sofie Biosciences for $945M
By
AuntMinnie.com staff writers
The deal is expected to close in the first half of 2027.
October 5, 2026
Radnostix to sell nuclear fuel processing assets for $13.5M
By
AuntMinnie.com staff writers
Assets include a U.S. Nuclear Regulatory Commission (NRC) license, patented technology, and related technical materials.
October 1, 2026
Eden selects Kiewit as partner for NM isotope facility
By
AuntMinnie.com staff writers
The project is expected to create 205 jobs and generate more than $1.5 billion in economic impact over 10 years.
September 28, 2026
Telix inks deal to acquire ITM for $1.65B
By
Erik L. Ridley
The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.
September 21, 2026
Curium gets FDA approval for Lu-177 injection for GEP-NETs
By
AuntMinnie.com staff writers
The radioligand therapy delivers targeted radiation to GEP-NETs by binding to somatostatin receptors expressed on these tumors.
September 15, 2026
Ionetix begins shipping At-211 in North America
By
AuntMinnie.com staff writers
Alpha emitters like At-211 deliver high-energy radiation over a very short range.
September 2, 2026
IU Health launches theranostics center
By
AuntMinnie.com staff writers
The center is supported by a $40 million commitment.
August 19, 2026
Radnostix reports revenue decline in Q2
By
AuntMinnie.com staff writers
The company attributed the revenue dip to two voluntary product recalls and the Cobalt-60 hot-cell shutdown.
August 13, 2026
ITM receives Complete Response Letter for ITM-11
By
AuntMinnie.com staff writers
The FDA stated that it's unable to approve the NDA in its present form.
August 10, 2026
Plus Therapeutics rebrands as Cerenome
By
AuntMinnie.com staff writers
The move reflects the company's evolution from a therapeutics-focused organization into an integrated central nervous system (CNS) oncology company.
August 3, 2026
Novartis secures expanded approval for Pluvicto
By
AuntMinnie.com staff writers
Pluvicto can now be used as therapy in patients with PSMA-positive metastatic hormone-sensitive prostate cancer, in combination with an androgen receptor pathway inhibitor.
July 31, 2026
Page 1 of 445
Next Page